Alcon’s surgical division is formed with seven associates.
With sales of $31 million, Alcon goes public, with a listing on the New York Stock Exchange.
Nestlé acquires Alcon.
Steve Martin, a sales representative at Ciba-Geigy created and presented a proposal on how the company should diversify its business by entering the soft contact lens market. On February 1, 1980, that proposal was approved and CIBA VISION was formed.
CIBA VISION becomes the first market with a visibly tinted soft contact lens, called CIBASOFT®.
BI-SOFT® is launched, the first FDA approved soft bifocal contact lens.
Launched SOFTCOLORS®, one of the first soft lenses to enhance eye color.
Alcon acquires Sharpoint, Inc., broadening its surgical manufacturing capabilities.
Alcon purchases CooperVision Surgical to become the world’s leading ophthalmic surgical company.
Launch of Focus®, the first soft contact lens exclusively for periodic replacement.
The FDA approves Alcon’s AcrySof® intraocular lens (IOL), representing the first time a material had been developed specifically for an IOL.
Ciba-Geigy merged with Sandoz to form Novartis. CIBA VISION became the eye care unit of Novartis.
NIGHT & DAY® launches, representing the first contact lens for up to 30 nights of continuous wear.
Alcon acquires Summit Autonomous and Grieshaber to enter into the refractive laser market and expand its line of retinal surgery instruments.
Alcon introduces OPTI-FREE® EXPRESS®, solution for cleaning and disinfecting soft contact lenses.
CIBA VISION acquired Wesley Jessen, a manufacturer of specialty contact lenses.
AOSEPT® (CLEAR CARE® in North America) launches as the first one-bottle, peroxide lens care solution without added preservatives.
Alcon launches the AcrySof® Natural IOL, which filters UV and high-energy blue light.
CIBA VISION launches O2OPTIX™ (later re-branded as AIR OPTIX®), a high oxygen transmissibility, breathable daily wear contact lens.
Alcon launches the AcrySof® ReSTOR® IOL quickly becoming a global leader in multifocal IOLs.
Alcon launches with the AcrySof® Toric IOL for cataract patients with astigmatism.
Alcon expands its product portfolio for LASIK surgery through the acquisition of WaveLight AG.
Alcon expands its AcrySof® line with the introduction of AcrySof® IQ ReSTOR® +3D multifocal IOL.
Alcon introduces the CONSTELLATION® Vision System for vitreoretinal surgery.
CIBA Vision launches AIR OPTIX® for Astigmatism, AIR OPTIX® AQUA, and DAILIES® AquaComfort Plus® contact lenses.
Alcon’s leading brand of intraocular lenses (IOLs), AcrySof®, exceeds 40 million implants.
Alcon expands its cataract surgical portfolio with the acquisition of LenSx Laser, Inc. Today, the LenSx® Laser is the global leader in cataract femtosecond laser technology.
Alcon launches the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) designed to address both astigmatism and presbyopia.
Alcon launched the world's first and only water gradient daily disposable contact lens, DAILIES TOTAL1®.
Alcon launches OPTI-FREE® PureMoist® Multi-Purpose Disinfecting Solution with Hydra-Glyde® Moisture Matrix for outstanding wettability.
The boards of Novartis and Alcon complete their merger agreement, giving Novartis 100% ownership of Alcon. The merger unites the strengths of Alcon and CIBA Vision into one eye care business, making Alcon the second-largest division of Novartis. Sales reach $10 billion.
Alcon acquires the ophthalmic division of SensoMotoric Instruments, providing Alcon with surgical guidance technology for use in cataract surgery.
Alcon acquires Endure Medical Systems offering advanced technology ophthalmic microscopes.
Alcon launches the industry's most advanced phacoemulsification technology platform, the CENTURION® Vision System.
Alcon launches VERION™ Reference Unit and the VERION™ Digital Marker an advanced surgical planning, imaging and guidance technology designed to provide greater accuracy and efficiency during cataract surgery.
Alcon expands its DAILIES® AquaComfort Plus® family of contact lenses with the introduction of multifocal and toric designs.
Alcon introduces AIR OPTIX® COLORS contact lenses, a monthly color-enhancing lens with silicone hydrogel technology available in nine natural-looking colors.
Alcon enters into an agreement with Verily (formerly Google Life Sciences) to license "smart lens" technology.
Alcon acquires WaveTec Vision, the developer of the first commercialized intra-operative aberrometry system for cataract surgery.
Alcon innovates in the IOL field by launching AcrySof® IQ PanOptix® trifocal IOLs and the UltraSert™ Pre-Loaded Delivery System.
Alcon launches next generation hydrogen peroxide lens care solution, AOSEPT® PLUS with HydraGlyde® Solution (CLEAR CARE® PLUS in North America).
The Alcon Experience Center, an eye health education and training center, opens at the Fort Worth, Texas global headquarters.
The NGENUITY® 3D Visualization System is launched, to aid in retinal surgery visualization.
Two new contact lens innovations are launched: Dailies Total1® Multifocal, the first and only water gradient lenses designed for people with presbyopia, and AIR OPTIX® plus HydraGlyde, which combines SmartShield Technology and HydraGlyde Moisture Matrix - for a unique combination of deposit protection and longer-lasting lens surface moisture.
Alcon enters into a strategic alliance with PowerVision, Inc. to develop fluid-based accommodating lens implants.
Alcon launches AcrySof® IQ PanOptix® Toric prebyopia-an-astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery.
The Novartis board of directors votes to spin off Alcon into a stand-alone company, which is expected to occur in spring 2019. The decision is subject to regulatory approvals and a final vote from the Novartis board of directors